cefmetazole has been researched along with Neutropenia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Enoki, Y; Hayashi, M; Igarashi, Y; Kojima, N; Liu, X; Matsumoto, K; Mizukami, Y; Morita, T; Nakamura, T; Taguchi, K; Takemura, W; Tashiro, S; Yokoyama, Y | 1 |
Akatsuka, J; Fujisawa, K; Hirotsu, T; Hoshi, Y; Ishida, Y; Ishidoya, N; Kobayashi, N; Ohira, M; Takayama, J; Uchiyama, H | 1 |
1 trial(s) available for cefmetazole and Neutropenia
Article | Year |
---|---|
[Clinical evaluation of aztreonam for infections accompanying febrile neutropenic children with hematologic disorders and solid tumors. A cooperative study].
Topics: Adolescent; Age Factors; Aztreonam; Bacterial Infections; Cefmetazole; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Hematologic Diseases; Humans; Male; Neoplasms; Neutropenia | 1990 |
1 other study(ies) available for cefmetazole and Neutropenia
Article | Year |
---|---|
Cefmetazole as an Alternative to Carbapenems Against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Infections Based on In Vitro and In Vivo Pharmacokinetics/Pharmacodynamics Experiments.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefmetazole; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Mice; Microbial Sensitivity Tests; Neutropenia | 2021 |